◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › HSCS

HeartSciences Inc. (HSCS) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-07-09

HeartSciences Inc. (HSCS) operates in the Medical Devices industry and is headquartered in Southlake, United States with about 15 employees. Its market capitalization is roughly $9 million. In the fiscal year ended 2025-04-30, HSCS reported $0M in revenue and ($9M) in net income.

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness.

Interactive charts & full statements → Open the HSCS valuation workbench →

HSCS Revenue & Earnings History — Annual Income Statement

Income statement2025-04-302024-04-302023-04-302022-04-30
Total Revenue$0M$0M$0M$0M
Gross Profit$0M$0M$0M$0M
Operating Income (EBIT)($8M)($6M)($6M)($5M)
Net Income($9M)($7M)($6M)($5M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HSCS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-01-312025-10-312025-07-312025-04-302025-01-312024-10-31
Total Revenue$0M$0M$0M$0M$0M
Gross Profit$0M$0M$0M$0M$0M
Operating Income (EBIT)($2M)($2M)($2M)($2M)($2M)
Net Income($2M)($2M)($2M)($2M)($2M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HSCS Free Cash Flow History

HSCS Balance Sheet History

Balance sheet2025-04-302024-04-302023-04-302022-04-30
Total Assets$4M$10M$3M$2M
Total Liabilities$4M$2M$3M$8M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HSCS viewer.

Other Companies in Medical Devices

← HSBCAll stocksHSDT →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.